ReviewClinical, cosmetic and investigational dermatology2016
Acne keloidalis nuchae: prevalence, impact, and management challenges.
Review in Clinical, cosmetic and investigational dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 92 citations in OpenAlex.
- Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances.American journal of clinical dermatology · 2026Review
- Case Report: Bimekizumab for dissecting cellulitis of the scalp.Frontiers in immunology · 2026Article
- Article
- Differential diagnosis of posterior scalp hair loss.Archives of dermatological research · 2024Review
- Acne Keloidalis Nuchae: A Multicenter Retrospective Study of 142 Hispanic Patients.Dermatology practical & conceptual · 2024Article
- [Pseudofolliculitis barbae in police students in Dakar: epidemiological and clinical aspects, and associated risk factors].Medecine tropicale et sante internationale · 2024Article
- Article
- Treatment of acne keloidalis nuchae and dissecting cellulitis of the scalp with diclofenac sodium gel: a case series.JAAD case reports · 2023Article
- An Update on Alopecia and its Association With Thyroid Autoimmune Diseases.TouchREVIEWS in endocrinology · 2023Review
- Acne keloidalis nuchae in a patient with atopic dermatitis treated with Janus kinase inhibitor upadacitinib.JAAD case reports · 2023Article
- Immune cells and associated molecular markers in dermal fibrosis with focus on raised cutaneous scars.Experimental dermatology · 2023Review
- A review of skin disease in military soldiers: challenges and potential solutions.Annals of medicine · 2023Review
- Unveiling a Shared Precursor Condition for Acne Keloidalis Nuchae and Primary Cicatricial Alopecias.Clinical, cosmetic and investigational dermatology · 2023Article
- Chronic itch in African Americans: an unmet need.Archives of dermatological research · 2022Review
- Article
- Acne Keloidalis Nuchae is Associated with Cutis Verticis Gyrata.Clinical, cosmetic and investigational dermatology · 2022Article
- Hypofractionated radiotherapy to treat acne keloidalis nuchae.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021Article
- A Retrospective Cohort Study and Clinical Classification System of Acne Keloidalis Nuchae.The Journal of clinical and aesthetic dermatology · 2021Article
- Surgical management of giant acne keloidalis nuchae lesions.Case reports in plastic surgery & hand surgery · 2021Article
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence.Clinical, cosmetic and investigational dermatology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acne keloidalis nuchae (AKN) also known as folliculitis keloidalis nuchae (FKN) is a chronic form of scarring folliculitis seen mostly in men of African descent. The term AKN is commonly used even though the condition is not a keloid, and the affected individuals do not have a tendency to develop keloids in other areas of the body. It is seen in post pubertal men and is rare after the age of 55 years. A few cases have been reported in females. which has been classified as a primary cicatricial alopecia since the exact cause of acne keloidalis (AK) remains unknown. However, a few inciting agents have been suggested which include androgens, inflammation, infection, trauma, genetics, and ingrowing hairs. AK shares some similar features with other forms of cicatricial alopecia and may occur together. Papules, pustules, and sometimes tumorous masses in the nuchal or occipital regions of the scalp hence the name "bumps" evolved in the environment. Despite its common occurrence, only a few seek help in hospital when lesions start to unsightly affect the individual's quality of life. The presences of the keloidal lesions are more stressful compared to the resulting alopecia. Various attempts to reduce the bumps with corrosives, acids, and car engine oils lead to larger lesions or unsightly scars. Active lesions produce bleeding during haircuts. This is worrisome as a couple of individuals with active AK share shaving instruments at the barber shop and are at risk of acquiring or transmitting blood-borne infections. There is an urgent need to encourage safe shaving habits and treatment of lesions at onset so as to prevent unsightly lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.